UNSPSC 51334104: Lurasidone hydrochloride

This classification denotes a serotonin antagonist and dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0P4I5851I. European Medicines Agency schedules Lurasidone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34204. Lurasidone hydrochloride generally arises in the molecular formula C28H36N4O2S.CLH. The term 'lurasidone hydrochloride' is a United States Adopted Name designation.

UNSPSC 51334104 Lurasidone hydrochloride is a Commodity code for a specific antipsychotic pharmaceutical, but the recent state and local procurement activity indexed to this code does not reflect purchases of lurasidone or related psychiatric medications. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 — solicits naloxone (an opioid antagonist) and drug deactivation systems for community health support, a product category entirely outside the code's pharmaceutical scope. The misalignment between the code's stated commodity and the actual solicitation signals either a data-entry error in the state or local procurement system or a broad-brush tagging practice that does not reflect the work being bought.

Seminole County's naloxone procurement represents the only indexed recent activity; no other state or local opportunities appear under this code in the provided record. Without additional opportunities showing genuine lurasidone purchases or related antipsychotic medication sourcing, the code shows no actionable pattern of state and local procurement activity. Firms pursuing pharmaceutical supply contracts to state or local health departments or correctional agencies should verify the correct UNSPSC coding in the relevant solicitation notices rather than relying on this code as a signal of active demand for psychiatric medications.